Ovarian Cancer Prognosis: Biomarkers for Prediction and Guidance
Received Date: Aug 01, 2025 / Published Date: Aug 29, 2025
Abstract
Prognostic biomarkers are essential for optimizing ovarian cancer treatment and improving patient outcomes. This compilation reviews established markers like CA125 and HE4, alongside novel indicators including BRCA mutations, ctDNA, microRNAs, immune cell infiltrates, and epigenetic modifications. The interplay of these markers, including multi-modal approaches, refines risk stratification and predicts treatment response. Emerging non-invasive methods like liquid biopsies offer future directions for prognosis.
Citation: Hwang DD (2025) Ovarian Cancer Prognosis: Biomarkers for Prediction and Guidance. Current Trends Gynecol Oncol 10: 283.
Copyright: 漏 2025 Dr. Daniel Hwang This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 296
- [From(publication date): 0-0 - Apr 18, 2026]
- Breakdown by view type
- HTML page views: 237
- PDF downloads: 59
